Cargando…

PDCD6 is an independent predictor of progression free survival in epithelial ovarian cancer

BACKGROUND: Programmed cell death 6 (PDCD6) beside its known proapoptotic functions may be a player in survival pathways in cancer. The purpose of this study is to further explore the roles of PDCD6 in epithelial ovarian cancer. METHODS: Lentiviral vector with shRNA for PDCD6 was used to investigate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Su, Dan, Xu, Haiyan, Feng, Jianguo, Gao, Yun, Gu, Linhui, Ying, Lisha, Katsaros, Dionyssios, Yu, Herbert, Xu, Shenhua, Qi, Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3305474/ https://www.ncbi.nlm.nih.gov/pubmed/22369209 http://dx.doi.org/10.1186/1479-5876-10-31

Ejemplares similares

Genotyping of stathmin and its association with clinical factors and survival in patients with ovarian cancer
por: YING, LISHA, et al.
Publicado: (2013)

Immune Checkpoint Inhibitors in Epithelial Ovarian Cancer: An Overview on Efficacy and Future Perspectives
por: Borella, Fulvio, et al.
Publicado: (2020)

Tumour-specific HMG-CoAR is an independent predictor of recurrence free survival in epithelial ovarian cancer
por: Brennan, Donal J, et al.
Publicado: (2010)

Paclitaxel is necessary for improved survival in epithelial ovarian cancers with homologous recombination gene mutations
por: Jean, Stephanie, et al.
Publicado: (2016)

Polyphyllin I inhibits the growth of ovarian cancer cells in nude mice
por: Gu, Linhui, et al.
Publicado: (2016)

Netrin-1 overexpression is predictive of ovarian malignancies
por: Papanastasiou, Anastasios D., et al.
Publicado: (2011)

Hormone Receptors and Epithelial Ovarian Cancer: Recent Advances in Biology and Treatment Options
por: Borella, Fulvio, et al.
Publicado: (2023)

Low expression of WWC1, a tumor suppressor gene, is associated with aggressive breast cancer and poor survival outcome
por: Wang, Zhanwei, et al.
Publicado: (2019)

Early-Stage epithelial ovarian cancer: Predictors of survival
por: Upadhyay, Avinash, et al.
Publicado: (2022)

Machine learning-based cluster analysis of immune cell subtypes and breast cancer survival
por: Wang, Zhanwei, et al.
Publicado: (2023)

TOP2A as marker of response to pegylated lyposomal doxorubicin (PLD) in epithelial ovarian cancers
por: Ghisoni, Eleonora, et al.
Publicado: (2019)

The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer
por: Popple, A, et al.
Publicado: (2012)

Vitamin D receptor upregulates lncRNA TOPORS-AS1 which inhibits the Wnt/β-catenin pathway and associates with favorable prognosis of ovarian cancer
por: Fu, Yuanyuan, et al.
Publicado: (2021)

microRNA-106a modulates cisplatin sensitivity by targeting PDCD4 in human ovarian cancer cells
por: LI, HAO, et al.
Publicado: (2014)

A predictive score for optimal cytoreduction at interval debulking surgery in epithelial ovarian cancer: a two- centers experience
por: Ghisoni, Eleonora, et al.
Publicado: (2018)

Total Polyunsaturated Fatty Acid Level in Abdominal Adipose Tissue as an Independent Predictor of Recurrence-Free Survival in Women with Ovarian Cancer
por: Salaun, Helene, et al.
Publicado: (2023)

Endometriosis is the independent prognostic factor for survival in Chinese patients with epithelial ovarian carcinoma
por: Ren, Tong, et al.
Publicado: (2017)

Transcriptional Characterization of Stage I Epithelial Ovarian Cancer: A Multicentric Study
por: Calura, Enrica, et al.
Publicado: (2019)

Loss of Programmed cell death 4 (Pdcd4) associates with the progression of ovarian cancer
por: Wei, Na, et al.
Publicado: (2009)

Ovarian seromucinous carcinoma: an independent epithelial ovarian cancer?
por: Hu, Yi, et al.
Publicado: (2023)

Pretreatment thrombocytosis as an independent predictive factor for chemoresistance and poor survival in epithelial ovarian cancer
por: Nakao, Sari, et al.
Publicado: (2020)

BPA Decreases PDCD4 in Bovine Granulosa Cells Independently of miR-21 Inhibition
por: Sabry, Reem, et al.
Publicado: (2022)

HLA-G Expression Is an Independent Predictor for Improved Survival in High Grade Ovarian Carcinomas
por: Rutten, M. J., et al.
Publicado: (2014)

FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients
por: Tassi, Renata A., et al.
Publicado: (2019)

Therapy Effects of Wogonin on Ovarian Cancer Cells
por: Ruibin, Jiang, et al.
Publicado: (2017)

High PTPN13 expression in high grade serous ovarian carcinoma is associated with a better patient outcome
por: D’Hondt, Véronique, et al.
Publicado: (2017)

Tumour Suppressive Function and Modulation of Programmed Cell Death 4 (PDCD4) in Ovarian Cancer
por: Wei, Na, et al.
Publicado: (2012)

PDCD2 sensitizes HepG2 cells to sorafenib by suppressing epithelial-mesenchymal transition
por: Liu, Hongyu, et al.
Publicado: (2019)

C-Fos expression is a molecular predictor of progression and survival in epithelial ovarian carcinoma
por: Mahner, S, et al.
Publicado: (2008)

Radiation therapy for epithelial ovarian cancer brain metastases: clinical outcomes and predictors of survival
por: Teckie, Sewit, et al.
Publicado: (2013)

Predictors of Survival Outcomes After Primary Treatment of Epithelial Ovarian Cancer in Lagos, Nigeria
por: Okunade, Kehinde Sharafadeen, et al.
Publicado: (2021)

Recombinant human PDCD5 (rhPDCD5) protein is protective in a mouse model of multiple sclerosis
por: Xiao, Juan, et al.
Publicado: (2015)

Identification of PDCD1 and PDCD1LG2 as Prognostic Biomarkers and Associated with Immune Infiltration in Hepatocellular Carcinoma
por: Li, Wang, et al.
Publicado: (2022)

A tumor DNA complex aberration index is an independent predictor of survival in breast and ovarian cancer
por: Vollan, Hans Kristian Moen, et al.
Publicado: (2014)

LncRNA ZNF582-AS1 Expression and Methylation in Breast Cancer and Its Biological and Clinical Implications
por: Wang, Junlong, et al.
Publicado: (2022)

ECOG is as independent predictor of the response to chemotherapy, overall survival and progression-free survival in carcinoma of unknown primary site
por: Grajales-Álvarez, Rocío, et al.
Publicado: (2017)

Deletion of Pdcd5 in mice led to the deficiency of placenta development and embryonic lethality
por: Li, Ge, et al.
Publicado: (2017)

Genome-wide analysis of copy number alterations led to the characterisation of PDCD10 as oncogene in ovarian cancer
por: De Marco, Carmela, et al.
Publicado: (2021)

Carbonyl reductase as a significant predictor of survival and lymph node metastasis in epithelial ovarian cancer
por: Umemoto, M, et al.
Publicado: (2001)

Psoas muscle index at the fifth lumbar vertebra as a predictor of survival in epithelial ovarian cancers
por: Yoshikawa, Tomoyuki, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dqp9g4rr57kvdspikqvnohtb6o